Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
DexCom, Inc. - Common Stock
(NQ:
DXCM
)
74.54
-0.60 (-0.80%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DexCom, Inc. - Common Stock
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
49
50
Next >
Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)
February 27, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom...
Via
StockStory
Topics
Artificial Intelligence
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
↗
February 26, 2025
Via
The Motley Fool
These S&P500 stocks are moving in today's pre-market session
↗
February 19, 2025
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.
Via
Chartmill
Insulet Earnings: What To Look For From PODD
February 19, 2025
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be announcing earnings results tomorrow after market close. Here’s what to expect.
Via
StockStory
iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect
February 19, 2025
Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results tomorrow afternoon. Here’s what investors should know.
Via
StockStory
DexCom Analysts Increase Their Forecasts After Q4 Earnings
↗
February 14, 2025
Via
Benzinga
Earnings Scheduled For February 13, 2025
↗
February 13, 2025
Via
Benzinga
Should You Buy DexCom Stock Before Feb. 13?
↗
February 06, 2025
Via
The Motley Fool
What's going on in today's session: S&P500 movers
↗
February 14, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Via
Chartmill
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
↗
February 14, 2025
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential.
Via
Benzinga
In today's session, there are S&P500 stocks with remarkable trading volume.
↗
February 14, 2025
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Via
Chartmill
Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday?
↗
February 14, 2025
Stocks are headed for weekly gains, with the Dow Jones dipping slightly and the S&P 500 and Nasdaq trading just above the flatline Friday.
Via
Benzinga
Topics
Stocks
Deep Dive Into DexCom Stock: Analyst Perspectives (5 Ratings)
↗
February 03, 2025
Via
Benzinga
Expert Outlook: DexCom Through The Eyes Of 11 Analysts
↗
January 16, 2025
Via
Benzinga
Discover which S&P500 stocks are making waves on Friday.
↗
February 14, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Via
Chartmill
Dexcom Q4 Earnings: Expanding Sales, New Products, Margin Pressure And More
↗
February 14, 2025
Dexcom reported Q4 results, with revenue up 8%, beating estimates. CEO looks forward to unlocking next wave of global access.
Via
Benzinga
DexCom (DXCM) Q4 2024 Earnings Call Transcript
↗
February 13, 2025
DXCM earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
DexCom: Revenue Up, EPS Misses Mark
↗
February 13, 2025
DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short.
Via
The Motley Fool
DexCom’s (NASDAQ:DXCM) Q4: Beats On Revenue
February 13, 2025
Medical device company DexCom (NASDAQ:DXCM) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 7.6% year on year to $1.11 billion. The company expects the full year’s...
Via
StockStory
Topics
Artificial Intelligence
Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock?
↗
January 16, 2025
Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.
Via
Chartmill
Dexcom Tumbles As Fourth-Quarter Profit Lags Expectations
↗
February 13, 2025
Dexcom stock fell late Thursday after the company missed fourth-quarter profit expectations by a nickel per share.
Via
Investor's Business Daily
Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results
February 13, 2025
From
DexCom, Inc.
Via
Business Wire
DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect
February 12, 2025
Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings tomorrow after the bell. Here’s what investors should know.
Via
StockStory
Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock?
↗
February 10, 2025
Based on a technical and fundamental analysis of NASDAQ:DXCM we can say: DEXCOM INC (NASDAQ:DXCM)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
Via
Chartmill
Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade
↗
February 03, 2025
Via
The Motley Fool
Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years
↗
February 03, 2025
Via
The Motley Fool
For those who appreciate growth without the sticker shock, NASDAQ:DXCM is worth considering.
↗
January 31, 2025
NASDAQ:DXCM is scoring great on several growth aspects while it also shows decent health and profitability. At the same time it remains remains attractively priced.
Via
Chartmill
Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time.
January 30, 2025
From
DexCom, Inc.
Via
Business Wire
Lululemon To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Thursday
↗
January 16, 2025
Via
Benzinga
This Netflix Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
↗
January 16, 2025
Via
Benzinga
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
49
50
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
